Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Appointment Michael Condren topic
No spam. Unsubscribe anytime.
Regents approve Michael Condren as interim CEO of UC Davis Health with $1.06 million salary
Summary
The UC Board of Regents Health Services Committee approved the interim appointment and compensation for Michael Condren as interim chief executive officer of UC Davis Health, effective Feb. 15, 2025, through Jan. 31, 2026, or until a permanent CEO is appointed.
The University of California Board of Regents Health Services Committee approved the appointment of Michael Condren as interim chief executive officer of UC Davis Health and authorized the proposed interim base salary of $1,062,600, effective Feb. 15, 2025, through Jan. 31, 2026, or until a new CEO is appointed.
The appointment and compensation were presented in open session after discussion in closed session by Vice President Reuben; the committee noted this is a Level 1 Senior Management Group (SMG) interim appointment. The committee conducted a roll call vote during the meeting; Regents present voted “aye” and the item was approved.
The committee did not specify the motion maker or seconder by name on the public record. Regents recorded on the roll call during the vote included Regent Bachelor, Regent Chu, Regent Drake, Liebe, Macarachian, Regent Park, Regent Riley and Regent Suarez. The item was listed on the meeting agenda as H1.
No additional details about contract provisions beyond the interim base salary and effective dates were provided in open session. The item’s materials and compensation specifics were discussed in closed session prior to the public vote, as noted by the committee chair.
